536 related articles for article (PubMed ID: 23278838)
1. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
Patel A; Holman RC; Callinan LS; Sreenivasan N; Schonberger LB; Fischer TK; Belay ED
Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
[TBL] [Abstract][Full Text] [Related]
2. Kawasaki syndrome and factors associated with coronary artery abnormalities in California.
Callinan LS; Tabnak F; Holman RC; Maddox RA; Kim JJ; Schonberger LB; Vugia DJ; Belay ED
Pediatr Infect Dis J; 2012 Sep; 31(9):894-8. PubMed ID: 22565293
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
Singh-Grewal D; Wong M; Isaacs D
J Paediatr Child Health; 2005; 41(9-10):495-9. PubMed ID: 16150066
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Kawasaki disease in older children.
Cai Z; Zuo R; Liu Y
Clin Pediatr (Phila); 2011 Oct; 50(10):952-6. PubMed ID: 21628347
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
Ruan Y; Ye B; Zhao X
Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of atypical Kawasaki disease.
Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM
J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122
[TBL] [Abstract][Full Text] [Related]
7. Atypical and complicated Kawasaki disease in infants. Do we need criteria?
Joffe A; Kabani A; Jadavji T
West J Med; 1995 Apr; 162(4):322-7. PubMed ID: 7747497
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease.
Sung RY; Ng YM; Choi KC; Mok GC; Cheng YW; Ho MH;
Pediatr Infect Dis J; 2006 Jun; 25(6):521-5. PubMed ID: 16732150
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
[TBL] [Abstract][Full Text] [Related]
10. Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease.
Dominguez SR; Anderson MS; El-Adawy M; Glodé MP
Pediatr Infect Dis J; 2012 Dec; 31(12):1217-20. PubMed ID: 22760536
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery dilatation in Incomplete Kawasaki disease.
Vijayan AP; Dinesh KB; Nath KR
Indian Pediatr; 2009 Jul; 46(7):607-9. PubMed ID: 19638661
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki disease in older children and adolescents.
Stockheim JA; Innocentini N; Shulman ST
J Pediatr; 2000 Aug; 137(2):250-2. PubMed ID: 10931420
[TBL] [Abstract][Full Text] [Related]
14. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
Sangtawesin C; Kirawitaya T; Layangkool T; Nawasiri W; Vimolsarawong N
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
[TBL] [Abstract][Full Text] [Related]
16. Kawasaki disease in Jordan: demographics, presentation, and outcome.
Al-Ammouri I; Al-Wahsh S; Khuri-Bulos N
Cardiol Young; 2012 Aug; 22(4):390-5. PubMed ID: 22067065
[TBL] [Abstract][Full Text] [Related]
17. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
Kobayashi T; Inoue Y; Morikawa A
Nihon Rinsho; 2008 Feb; 66(2):332-7. PubMed ID: 18260333
[TBL] [Abstract][Full Text] [Related]
18. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center].
Raith W; Gamillscheg A; Heinzl B; Nagel BH; Koestenberger M; Beitzke A
Klin Padiatr; 2009; 221(2):83-8. PubMed ID: 19263328
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki disease: part II. Complications and treatment.
Bayers S; Shulman ST; Paller AS
J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
[TBL] [Abstract][Full Text] [Related]
20. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003.
Belay ED; Maddox RA; Holman RC; Curns AT; Ballah K; Schonberger LB
Pediatr Infect Dis J; 2006 Mar; 25(3):245-9. PubMed ID: 16511388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
